黄芪注射液联合超声雾化吸入治疗小儿支气管炎急性发作的临床效果和安全性

Clinical Efficacy and Safety of Astragalus Injection Combined with Ultrasonic Aerosol Inhalation in the Treatment of Children with Acute Episode of Bronchitis

目的:探讨黄芪注射液联合超声雾化吸入治疗小儿支气管炎急性发作的临床效果和安全性。方法:选择在笔者所在医院就诊的支气管炎急性发作患儿100例,其中50例行超声雾化吸入治疗(对照组),50例行黄芪注射液联合超声雾化吸入治疗(观察组),比较两组的临床疗效和安全性。结果:观察组总有效率明显高于对照组,组间比较差异有统计学意义(P<0.05)。观察组不良反应发生率略高于对照组,但差异无统计学意义(P>0.05)。结论:黄芪注射液联合超声雾化吸入治疗小儿支气管炎急性发作效果佳,可作为优先选择方式。

Objective：To investigate the clinical efficacy and safety of Astragalus Injection combined with ultrasonic aerosol inhalation in the treatment of children with acute episode of bronchitis.Method：In our hospital,100 children with bronchitis acute attack were selected,50 cases were treated by ultrasonic atomizing inhalation therapy（the control group）,50 cases were treated by Huangqi Injection combined with ultrasonic atomizing inhalation therapy（the observation group）,the clinical efficacy and safety in two groups were compared.Result：The total effective rate of the observation group was significantly higher than that of the control group,the difference was statistically significant（P〈0.05）.The incidence of adverse reactions in the observation group was slightly higher than that in the control group,but the difference was not statistically significant（P〉0.05）.Conclusion：The therapeutic effect of Astragalus Injection combined with ultrasonic atomizing inhalation in the treatment of children with acute episode of bronchitis is better,which can be used as a preferred choice.